YABAO PHARM.CORP(SH:600351) Xin Lang Cai Jing·2025-08-16 02:16Core Viewpoint - Yabao Pharmaceutical (600351.SH) reported its half-year results for 2025, indicating a total institutional ownership of 161 million shares, representing 22.94% of the company's total equity, with a slight decline in institutional holding compared to the previous quarter [1] Institutional Ownership - As of August 15, 2025, six institutional investors disclosed their holdings in Yabao Pharmaceutical, with a combined shareholding of 161 million shares [1] - The institutional investors include Shanxi Yabao Investment Group Co., Ltd., Hong Kong Central Clearing Limited, Datong Traditional Chinese Medicine Factory, and others [1] - The total institutional holding percentage decreased by 0.35 percentage points compared to the previous quarter [1] Public Fund Holdings - During this reporting period, only one public fund, Huatai-PineBridge CSI Traditional Chinese Medicine ETF, was disclosed, remaining unchanged from the previous quarter [1]